Results 51 to 60 of about 19,855 (299)

Lattice Structures for Bone Replacement: The Intersection of Bone Biomechanics, Lattice Design, and Additive Manufacturing

open access: yesAdvanced Materials Technologies, EarlyView.
This review outlines how understanding bone's biology, hierarchical architecture, and mechanical anisotropy informs the design of lattice structures that replicate bone morphology and mechanical behavior. Additive manufacturing enables the fabrication of orthopedic implants that incorporate such structures using a range of engineering materials ...
Stylianos Kechagias   +4 more
wiley   +1 more source

Routine use of patient-reported experience and outcome measures for children and young people: a scoping review

open access: yesSystematic Reviews
Background Patient-reported outcome measures (PROMs) measure people’s views of their health status whereas patient-reported experience measures (PREMs) are questionnaires measuring perceptions of their experience whilst receiving healthcare.
Anne Alarilla   +8 more
doaj   +1 more source

Use patient reported outcome measures (PROMs) in treatment of long covid [PDF]

open access: yesBMJ, 2021
The challenges outlined in Sivan and colleagues’ commentary on Ayoubkhani and colleagues’ evidence of the scope and scale of long covid may be even greater than described.1 Teams with staff able to tackle symptoms related to multiple systems will be essential.
openaire   +2 more sources

Effect and Threshold of Endoscopic Findings for CRS Control Status and Long‐Term Outcome Prediction

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background EPOS 2020 defined chronic rhinosinusitis (CRS) disease control using patient symptoms and medication usage but endoscopic findings were considered optional. The effect of adding endoscopic features, an appropriate threshold, and their association with present or future symptom control have not been studied.
Steven Chun‐Kang Liao   +14 more
wiley   +1 more source

Added value of patient-reported outcome measures (PROMs) after an acute stroke and early predictors of 90 days PROMs

open access: yesJournal of Patient-Reported Outcomes, 2022
Introduction Value-based health care represents a patient-centered approach by valuing Patient-Reported Outcome Measures (PROMs). Our aim was to describe the additional value of PROMs after an acute stroke over conventional outcome measures and to ...
Ester Sanchez-Gavilan   +10 more
doaj   +1 more source

Loss to patient-reported outcome measure follow-up after hip arthroplasty and knee arthroplasty patient satisfaction, associations with non-response, and maximizing returns

open access: yesBone & Joint Open, 2022
Aims The aim of this study was to determine satisfaction rates after hip and knee arthroplasty in patients who did not respond to postoperative patient-reported outcome measures (PROMs), characteristics of non-responders, and contact preferences to ...
Lauren A. Ross   +5 more
doaj   +1 more source

Patients Reported Outcomes Measures (PROMs) Trajectories After Elective Hip Arthroplasty: A Latent Class Growth Analysis [PDF]

open access: green, 2021
Davide Golinelli   +10 more
openalex   +1 more source

Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic Rhinosinusitis

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Appropriate medical therapy (AMT) is first‐line treatment for patients with chronic rhinosinusitis (CRS). We evaluated inflammatory structure, treatment‐induced changes, and biomarker‐outcome associations in AMT‐managed patients. Methods Fifty‐one CRS patients were evaluated before and after AMT which included a combination of oral ...
Asher C. Park   +9 more
wiley   +1 more source

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas

open access: yesAnnals of Neurology, EarlyView.
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek   +7 more
wiley   +1 more source

Systematic review and standardised assessment of Chinese cross-cultural adapted hip Patient Reported Outcome Measures (PROMs).

open access: yesPLoS ONE, 2021
PurposeTo perform a systemic literature search to identify Chinese cross culturally adapted and new designed Patient Reported Outcome Measures (PROMs) used for hip assessment, then a standardized evaluation of available instruments in order to provide ...
James Reeves Mbori Ngwayi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy